您好,欢迎来到阿仪网! 请登录 免费注册

诚信档案

MedChemExpress

第10年

当前位置:阿仪网    >   生物试剂/抗体/细胞    >   生化试剂    >  其他    >  MedChemExpress   >   产品展示    >  MCE信号通路    >   细胞周期/DNA 损伤   >   Rosiglitazone hydrochloride

Rosiglitazone hydrochloride

参考价¥咨询
型号
  • 参考价咨询
  • 型号
  • 品牌 $brandModel.Title
  • 所属地区美洲
  • 原产地上海-上海市
  • 产品摘要

    Rosiglitazone hydrochloride (BRL 49653 hydrochloride) 是一种选择性的,具有口服活性 PPARγ 激动剂,对 PPARγ1、PPARγ2 和 PPARγ 的 EC50 值分别为 30 nM、100 nM 和 60 nM。Rosiglitazone hydrochloride 与 PPARγ 结合,Kd 约为 40 nM。Rosiglitazone hydrochloride 也是 TRPC5 的激活剂 (EC50=∼30 μM) 和 TRPM3 的抑制剂


服务

  • 品质保障·资金安全·售后无忧

产品完善度:

更新时间:2026/10/7 8:41:50关注度:2456

关键词标签:Avandia

支付方式:

  • 支付宝 微信 银行转账

MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务。

Rosiglitazone hydrochloride

CAS No. : 302543-62-0

MCE 国际站:Rosiglitazone hydrochloride

产品活性:Rosiglitazone hydrochloride (BRL 49653 hydrochloride) 是一种选择性的,具有口服活性 PPARγ 激动剂,对 PPARγ1、PPARγ2 和 PPARγ 的 EC50 值分别为 30 nM、100 nM 和 60 nM。Rosiglitazone hydrochloride 与 PPARγ 结合,Kd 约为 40 nM。Rosiglitazone hydrochloride 也是 TRPC5 的激活剂 (EC50=∼30 µM) 和 TRPM3 的抑制剂。

研究领域:Cell Cycle/DNA Damage | Neuronal Signaling | Membrane Transporter/Ion Channel | Autophagy | Apoptosis

作用靶点:PPAR | TRP Channel | Autophagy | Ferroptosis

In Vitro: Rosiglitazone is a potent and selective activator of PPARγ, with EC50s of 30 nM and 100 nM for PPARγ1 and PPARγ2, respectively, and a Kd of appr 40 nM for PPARγ. Rosiglitazone (BRL49653, 0.1, 1,10 µM) promotes differentiation of C3H10T1/2 stem cells to adipocytes. Rosiglitazone (Compound 6) activates PPARγ, with an EC50 of 60 nM. Rosiglitazone (1 µM) activates PPARγ, which binds to NF-α1 promoter to activate gene transcription in neurons. Rosiglitazone (1 µM) also protects Neuro2A cells and hippocampal neurons against oxidative stress, and up-regulates BCL-2 expression in an NF-α1-dependent manner. Rosiglitazone completely inhibits TRPM3 with IC50 values of 9.5 and 4.6 µM against nifedipine- and PregS-evoked activity, but such effects are not via PPARγ. Rosiglitazone inhibits TRPM2 at higher concentration, with an IC50 of appr 22.5 µM. Rosiglitazone is a strong stimulator of TRPC5 channels, with an EC50 of ~30 µM.

In Vivo: Rosiglitazone (5 mg/kg, p.o.) decreases the serum glucose in diabetic rats. Rosiglitazone also decreases IL-6, TNF-α, and VCAM-1 levels in diabetic group. Rosiglitazone in combination with losartan increases glucose compared to diabetic and Los-treated groups. Rosiglitazone significantly ameliorates endothelial dysfunction indicated by a significantly lower contractile response to PE and Ang II and enhancement of ACh-provoked relaxation in aortas isolated from diabetic rats.

相关产品:Erastin | Ferrostatin-1 | Cisplatin | Cycloheximide | RSL3 | Acetylcysteine | Deferoxamine mesylate | SP600125 | Necrostatin-1 | Retinoic acid | Rosiglitazone | SB 202190 | GW9662 | Capsaicin | Curcumin | Hemin | (-)-Epigallocatechin Gallate | TBHQ | Simvastatin | Diphenyleneiodonium chloride | Bardoxolone methyl | U⁻⁷3122 | Pifithrin-α hydrobromide | Lovastatin | Trolox | EIPA | Eprenetapopt | L-Glutathione reduced | Amiloride hydrochloride | GW6471

品牌介绍:
• MCE (MedChemExpress) 拥有数百种全球独家化合物,我们致力于为全球科研客户提供最新最全的高品质小分子活性化合物;
• 10,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领域;
• 设有专业的实验中心和严格的质控、验证体系;
• 提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告,确保产品的高纯度、高品质;
• 产品的生物活性多经各国客户实验验证;
• Nature, Cell, Science 等多种顶级期刊及制药专利收录了MCE客户的科研成果;
• 专业团队跟踪最新的制药及生命科学研究进展,为您提供全球最新的活性化合物;
• 与世界各大制药公司及知名科研机构建立了长期的合作。

1000+ Inhibitors&Agonists 作用于20多条经典信号通路
30+ Screening Libraries 疾病机制研究的高效工具
CCK8 Kit | Cell Counting Kit-8
FDA-Approved 药物筛选库
Inhibitor Cocktails 蛋白酶, 磷酸酶 & 去乙酰化酶
Top Publications Citing Use of MCE
MCE Hotline: 4008203792 | 中国现货 - 全球文献引用 - 高纯度高品质 - 全方位技术支持



推荐产品




快速导航

在线咨询5分钟应答

提交